Quote:
Originally Posted by TrentCrimmIndependent
There is a risk with the latter of course, but the upside of it panning out greatly out-weighs the former. In both the importance of the role and longevity.
|
I mean yeah, if you get to declare that it out-weighs then no one can argue your declaration.
basically your argument is:
1) you know the true upside of pospisil
2) you know who we will draft at 10 and that the player will make the nhl and outperform pospisil
But you don’t know. You’re taking the biggest unknowns and declaring them fait accompli. They’re not.
Again, if pospisil is packaged with Markstrom so that we can get a player in addition to the 10 then I’m all ears. If pospisil is added to Markstrom in order to secure the 10 only, I’m out.